{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T11:10:59Z","timestamp":1780053059473,"version":"3.54.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.neuint.2013.07.002","type":"journal-article","created":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T02:45:20Z","timestamp":1374029120000},"page":"316-321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Protective effect of nebivolol on reserpine-induced neurobehavioral and biochemical alterations in rats"],"prefix":"10.1016","volume":"63","author":[{"given":"V.S.","family":"Nade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.V.","family":"Shendye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.A.","family":"Kawale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.R.","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.L.","family":"Khatri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.neuint.2013.07.002_b0005","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s00213-002-1081-7","article-title":"Effects of melatonin on orofacial movements in rats","volume":"161","author":"Abilio","year":"2002","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1016\/j.neuint.2013.07.002_b0010","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0301-0082(99)00064-7","article-title":"Neurotoxicity associated with neuroleptic induced oral dyskinesias in rats","volume":"61","author":"Andreassen","year":"2000","journal-title":"Prog. Neurobiol."},{"issue":"5","key":"10.1016\/j.neuint.2013.07.002_b0015","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0278-5846(01)00333-5","article-title":"Evaluation of face validity of reserpine administration as an animal model of depression-Parkinson\u2019s disease association","volume":"26","author":"Andreatini","year":"2002","journal-title":"Prog. Neuro-psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuint.2013.07.002_b0020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1212\/01.WNL.0000148609.35718.7D","article-title":"Vitamin E for prophylaxis against chemotherapy-induced neuropathy: a randomized controlled trial","volume":"64","author":"Argyriou","year":"2005","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neuint.2013.07.002_b0025","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0278-5846(02)00344-5","article-title":"Ebselen attenuates reserpine induced orofacial dyskinesia and oxidative stress in rat striatum","volume":"27","author":"Burger","year":"2003","journal-title":"Prog. Neuro-psychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.neuint.2013.07.002_b0030","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.brainresbull.2004.09.006","article-title":"Effects of age on reserpine-induced orofacial dyskinesia and possible protection of diphenyldiselenide","volume":"64","author":"Burger","year":"2004","journal-title":"Brain. Res. Bulletin"},{"key":"10.1016\/j.neuint.2013.07.002_b0035","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.brainres.2004.10.038","article-title":"Acute reserpine and subchronic haloperidol treatments change synaptosomal brain glutamate uptake and elicit orofacial dyskinesia in rats","volume":"1031","author":"Burger","year":"2005","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.neuint.2013.07.002_b0040","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.pbb.2012.01.007","article-title":"Resveratrol reduces vacuous chewing movements induced by acute treatment with fluphenazine","volume":"101","author":"Busanello","year":"2012","journal-title":"Pharmacol. Biochem. Behavior"},{"key":"10.1016\/j.neuint.2013.07.002_b0045","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1749-6632.1989.tb14918.x","article-title":"Possible involvement of free radicals in neuroleptic-induced movement disorders: evidence from treatment of tardive dyskinesia with Vitamin E","volume":"570","author":"Cadet","year":"1989","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.neuint.2013.07.002_b0050","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0278-5846(01)00255-X","article-title":"The mitochondrial toxin 3-nitropropionic acid aggravates reserpine-induced oral dyskinesia in rats","volume":"26","author":"Calvente","year":"2002","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuint.2013.07.002_b0055","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/1801200a0","article-title":"3,4-Dihydroxyphenylalanine and 5-hydroxy tryptophan as reserpine antagonists","volume":"180","author":"Carlsson","year":"1957","journal-title":"Nature"},{"issue":"Suppl. 4","key":"10.1016\/j.neuint.2013.07.002_b0060","first-page":"5","article-title":"Tardive dyskinesia: pathophysiology and animal models","volume":"61","author":"Casey","year":"2000","journal-title":"J. Clin. Psychiatry"},{"issue":"10","key":"10.1016\/j.neuint.2013.07.002_b0065","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/j.jacc.2003.06.011","article-title":"Nebivolol and its 4-ketoderivative increase nitric oxide in endothelial cells by reducing its oxidative inactivation","volume":"42","author":"Cominacini","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5134","key":"10.1016\/j.neuint.2013.07.002_b0070","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1126\/science.7901908","article-title":"Oxidative stress, glutamate and neurodegenerative disorders","volume":"262","author":"Coyle","year":"1993","journal-title":"Science"},{"issue":"9\u201310","key":"10.1016\/j.neuint.2013.07.002_b0080","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1089\/ars.2005.7.1223","article-title":"Oxidative and antioxidative potential of brain microglial cells","volume":"7","author":"Dringen","year":"2005","journal-title":"Antioxid. Redox Signal."},{"issue":"1","key":"10.1016\/j.neuint.2013.07.002_b0085","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","article-title":"Tissue sulfhydryl groups","volume":"82","author":"Ellman","year":"1959","journal-title":"Arch. Biochem. Biophys."},{"issue":"7","key":"10.1016\/j.neuint.2013.07.002_b0090","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.pnpbp.2007.06.028","article-title":"Valeriana officinalis does not alter the orofacial dyskinesia induced by haloperidol in rats: role of dopamine transporter","volume":"31","author":"Fachinetto","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.neuint.2013.07.002_b0095","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0278-5846(01)00255-X","article-title":"The mitochondrial toxin 3-nitropropionic acid aggravates reserpine-induced oral dyskinesia in rats","volume":"26","author":"Filho","year":"2002","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuint.2013.07.002_b0100","first-page":"75","article-title":"Effects of nebivolol on endothelial gene expression during oxidative stress in human umbilical vein endothelial cells","volume":"36","author":"Garbin","year":"2008","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.neuint.2013.07.002_b0105","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jchemneu.2005.01.001","article-title":"Vitamin E against damage caused by formaldehyde in frontal cortex and hippocampus: biochemical and histological studies","volume":"29","author":"Gurel","year":"2005","journal-title":"J. Chem. Neuroanat."},{"issue":"11\u201312","key":"10.1016\/j.neuint.2013.07.002_b0110","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.lfs.2011.12.001","article-title":"Nebivolol regulates eNOS and iNOS expressions and alleviates oxidative stress in cerebral ischemia\/reperfusion injury in rats","volume":"90","author":"Heeba","year":"2012","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.neuint.2013.07.002_b0120","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2165\/11530710-000000000-00000","article-title":"Nebivolol: haemodynamic effects and clinical significance of combined beta-blockade and nitric oxide release","volume":"70","author":"Kamp","year":"2010","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.neuint.2013.07.002_b0125","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1744-6163.2001.tb00614.x","article-title":"Drugs used for cognitive symptoms of Alzheimer\u2019s disease","volume":"37","author":"Keltner","year":"2001","journal-title":"Perspect. Psychiatry Care"},{"issue":"1","key":"10.1016\/j.neuint.2013.07.002_b0130","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0003-9861(78)90479-4","article-title":"Generation of superoxide radical during autooxidation of hydroxylamine and an assay for superoxide dismutase","volume":"186","author":"Kono","year":"1978","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.neuint.2013.07.002_b0135","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1051\/ocl.2000.0258","article-title":"Vitamin E. Current state of knowledge, role in the prevention of cardiovascular disease, bioavailability","volume":"7","author":"Leger","year":"2000","journal-title":"Oleagineux Corps Gras Lipides"},{"issue":"1","key":"10.1016\/j.neuint.2013.07.002_b0140","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin\u2013Phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2013.07.002_b0145","series-title":"Methods of Enzymatic Analysis","first-page":"885","article-title":"Catalase","author":"Luck","year":"1971"},{"issue":"1","key":"10.1016\/j.neuint.2013.07.002_b0150","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1097\/01.fjc.0000238593.67191.e2","article-title":"Effect of nebivolol on endothelial nitric oxide and peroxynitrite release in hypertensive animals: role of antioxidant activity","volume":"48","author":"Mason","year":"2006","journal-title":"Cardiovasc. Pharmacol."},{"key":"10.1016\/j.neuint.2013.07.002_b0155","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1161\/01.ATV.0000065234.70518.26","article-title":"Nebivolol prevents vascular NOS III uncoupling in experimental hyperlipidemia and inhibits NADPH oxidase activity in inflammatory cells","volume":"23","author":"Mollnau","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.neuint.2013.07.002_b0160","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000074669","article-title":"Reversal of reserpine-induced orofacial dyskinesia and cognitive dysfunction by quercetin","volume":"70","author":"Naidu","year":"2004","journal-title":"Pharmacology"},{"issue":"2","key":"10.1016\/j.neuint.2013.07.002_b0165","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1089\/109662003322233503","article-title":"Effect of Withania somnifera roots extract on haloperidol induced orofacial dyskinesia: possible mechanism of action","volume":"6","author":"Naidu","year":"2003","journal-title":"J. Med. Food."},{"issue":"1","key":"10.1016\/j.neuint.2013.07.002_b0170","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF02244874","article-title":"Dose dependant differences in the development of induced oral dyskinesia in rats: support for a model of Tardive dyskinesia","volume":"116","author":"Neisewander","year":"1994","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuint.2013.07.002_b0175","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2710.2006.00718.x","article-title":"Effect of treatment with nebivolol on parameters of oxidative stress in type 2 diabetes with mild to moderate hypertension","volume":"31","author":"Peter","year":"2006","journal-title":"J. Clin. Pharm. Ther."},{"issue":"17","key":"10.1016\/j.neuint.2013.07.002_b0180","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJM199704243361704","article-title":"A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer\u2019s disease. The Alzheimer\u2019s disease Cooperative Study","volume":"336","author":"Sano","year":"1997","journal-title":"N. Eng. J. Med."},{"key":"10.1016\/j.neuint.2013.07.002_b0185","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bbr.2012.03.008","article-title":"Repeated treatment with a low dose of reserpine as a progressive model of Parkinson\u2019s disease","volume":"231","author":"Silva","year":"2012","journal-title":"Behav. Brain Res."},{"issue":"13","key":"10.1016\/j.neuint.2013.07.002_b0195","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0024-3205(98)00042-3","article-title":"Effects of haloperidol and GM1 ganglioside treatment on striatal D2 receptor binding and dopamine turnover","volume":"62","author":"Vital","year":"1998","journal-title":"Life Sci."},{"key":"10.1016\/j.neuint.2013.07.002_b0200","series-title":"Drug Discovery and Evaluation: pharmacological assays","first-page":"391","author":"Vogel","year":"2002"},{"key":"10.1016\/j.neuint.2013.07.002_b0205","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1042\/bj0990667","article-title":"Mechanism of lipid peroxide formation in animal tissues","volume":"99","author":"Wills","year":"1966","journal-title":"Biochem. J."},{"issue":"13","key":"10.1016\/j.neuint.2013.07.002_b0210","first-page":"833","article-title":"Effects of beta-adrenergic receptor antagonists on oxidative stress in purified rat retinal ganglion cells","volume":"11","author":"Yu","year":"2007","journal-title":"Mol. Vis."}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018613001915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018613001915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T12:02:31Z","timestamp":1646136151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018613001915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0197018613001915"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2013.07.002","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective effect of nebivolol on reserpine-induced neurobehavioral and biochemical alterations in rats","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2013.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}